pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
590
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
seltorexant
Insomnia
Orexin receptor type 2
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 3
seralutinib
Pulmonary Arterial Hypertension
Platelet-derived growth factor receptor
Macrophage colony-stimulating factor 1 receptor
$GOSS
Gossamer Bio, Inc.
0
catalysts
Phase 3
← prev
page 18 of 20
next →
131
Pain
89
Neurology
1
setrusumab
Osteogenesis Imperfecta
Sclerostin
$RARE
Ultragenyx Pharmaceutical Inc.
0
catalysts
Phase 3
sevasemten
Becker Muscular Dystrophy
$EWTX
Edgewise Therapeutics, Inc.
0
catalysts
Phase 3
simoladagene autotemcel
Adenosine Deaminase (ADA) Deficiency Related SCID
Rarity PBC
0
catalysts
Phase 3
sirolimus
QTORIN rapamycin (sirolimus)
Lymphangioleiomyomatosis
Peptidyl-prolyl cis-trans isomerase FKBP1A
OrphAI Therapeutics Inc
0
catalysts
Phase 3
sitravatinib malate
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 3
sodium benzoate
NaBen (sodium benzoate)
Schizophrenia
SyneuRx International (Taiwan) Corp
0
catalysts
Phase 3
sodium iodide
sodium iodide [USP]
Myocardial Infarction
Faraday Pharmaceuticals Inc
0
catalysts
Phase 3
sodium oxybate ER
Lumryz (sodium oxybate)
Idiopathic Hypersomnia (IH)
GABA-B receptor
Avadel Pharmaceuticals Plc
0
catalysts
Phase 3
sofetabart mipitecan
Fallopian Tube Cancer
Eli Lilly and Co
0
catalysts
Phase 3
sonelokimab
Psoriatic Arthritis
Interleukin-17A
Interleukin-17F
$MLTX
MoonLake Immunotherapeutics
0
catalysts
Phase 3
sonesitatug vedotin
Adenocarcinoma Of The Gastroesophageal Junction
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 3
sonpiretigene isteparvovec
Retinitis Pigmentosa (Retinitis)
Nanoscope Therapeutics Inc
0
catalysts
Phase 3
sovateltide
Tycamzzi (sovateltide)
Acute Ischemic Stroke
Pharmazz Inc
0
catalysts
Phase 3
spartalizumab
Pancreatic Cancer
Programmed cell death protein 1
$NVS
NOVARTIS AG
0
catalysts
Phase 3
surabgene lomparvovec
Wet (Neovascular / Exudative) Macular Degeneration
$ABBV
AbbVie Inc.
0
catalysts
Phase 3
survodutide
Liver Fibrosis
Glucagon-like peptide 1 receptor
Glucagon receptor
Boehringer Ingelheim International GmbH
0
catalysts
Phase 3
tadekinig alfa
tadekinig alfa [INN]
Hemophagocytic Lymphohistiocytosis
AB2 Bio Ltd
0
catalysts
Phase 3
tafasitamab
Monjuvi (tafasitamab)
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD19
$INCY
INCYTE CORP
0
catalysts
Phase 3
talditercept alfa
Spinal Muscular Atrophy (SMA)
$BHVN
Biohaven Ltd.
0
catalysts
Phase 3
tanruprubart
tanruprubart [INN]
Guillain-Barre Syndrome
$ANNX
Annexon, Inc.
0
catalysts
Phase 3
tarcocimab tedromer
Retinal Vein Occlusion
$KOD
Kodiak Sciences Inc.
0
catalysts
Phase 3
tavilermide
Keratoconjunctivitis Sicca (Dry Eye)
Mimetogen Pharmaceuticals Inc
0
catalysts
Phase 3
tazbentetol
tazbentetol [INN]
Amyotrophic Lateral Sclerosis
Spinogenix Inc
0
catalysts
Phase 3
tecarfarin sodium
Thromboembolism
$CVKD
Cadrenal Therapeutics, Inc.
0
catalysts
Phase 3
thrombomodulin alfa
Disseminated Intravascular Coagulation (DIC)
Asahi Kasei Therapeutics Corp
0
catalysts
Phase 3
tideglusib
tideglusib [INN]
Myotonic Dystrophy
Venca Research Inc
0
catalysts
Phase 3
tifcemalimab
tifcemalimab [INN]
Small-Cell Lung Cancer
Shanghai Junshi Biosciences Co Ltd
0
catalysts
Phase 3
timbetasin acetate
Neurotrophic Keratitis
ReGenTree LLC
0
catalysts
